Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
Novel transcatheter tricuspid valve devices from Abbott Laboratories and Edwards Lifesciences have been enrolled as pilot cases in CMS’ new Transitional Coverage for Emerging Technologies (TCET) pathway.
Expediency is key in diagnosing autism spectrum disorder to give young children the best chance of success in their learning development. This Decatur, GA-based start-up enables providers to alleviate the mounting backlog of diagnoses using an objective software tool.
The International Medical Device Regulators Forum accepts new members and approves new guides. Excerpted from Pathways’ Picks October 9: TCET Tricuspid Valve Tryout, EtO Actions, IMDRF Updates, and More.